From: Serum miR-122 correlates with short-term mortality in sepsis patients
Category | Variables | Sepsis (n = 232) |
---|---|---|
Demographic parameters | Gender (male/female) | 169/63 |
Age in years (median (range)) | 59 (19, 91) | |
Clinical parameters | ICU type | |
Medical | 232 (100%) | |
Cardiac | 79 (34.05%) | |
Surgical | 95 (40.95%) | |
Trauma | 25 (10.77%) | |
Cancer | 24 (10.34%) | |
Other | 15 (6.46%) | |
APACHE II score | 18 (1, 39) | |
SOFA score | 7 (0, 19) | |
Acute kidney injury | 61 (26.29%) | |
Mechanical ventilation | 171 (73.71%) | |
Heat failure | 121 (52.15%) | |
Liver failure | 103 (44.39%) | |
ARDS | 60 (28.17%)a | |
28-day mortality | 45.69% | |
Biomarkers | miR-122 | 17.75 ± 3.40 cycles |
miR-193b* | 17.73 ± 4.81 cycles | |
miR-574-5p | 21.19 ± 3.64 cycles | |
miR-483-5p | 18.99 ± 4.24 cycles | |
CRP (mg/dl) | 8.9 (0.1, 35) | |
PCT (ng/ml) | 4.63 (0.05,119.44) |